WhiteSwell is a science-driven company dedicated to improving treatment of acute decompensated heart failure (ADHF), a primary cause of repeat hospitalization and emergency room visits.  The company is pioneering a minimally invasive catheter-based approach designed to more efficiently remove excess interstitial fluid in patients with ADHF by enhancing the natural fluid removal process of the lymphatic system. For more information visit www.whiteswell.com.

Life Sciences

Health Care

Medical Devices

WhiteSwell

Eamon Brady

Michael Jonas

Alva Bradley

George Bakris

Suzanne Hansel

Joann Lindenfeld

Ronan Keating

Martin Keegan

Jill Amstutz

Ann Marie Cannon

Andrew Levin

Andrew Farquharson

Seán Mac Réamoinn

The Medical Professionals team at WhiteSwell comprises experts in cardiology, nephrology, and structural heart disease who collaborate on developing and refining the company's innovative catheter-based approach to treating acute decompensated heart failure (ADHF). Their roles include conducting clinical research, advancing medical protocols, and ensuring the efficacy and safety of the treatment through specialized medical and clinical oversight.

Medical Professionals

Leadership Team

Research and Development

��

Medical Professionals

About

Team members

Other teams at WhiteSwell

Leadership Team

Research and Development

��������

Medical Professionals

About

Team members

Other teams at WhiteSwell

Leadership Team

Research and Development

��